Cisplatin treatment increases stemness through upregulation of hypoxia‐inducible factors by interleukin‐6 in non‐small cell lung cancerFuquan Zhang, Yuhchyau Chen|Cancer Science|2016Cited by 87
Radiation alters PD-L1/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK/Erk signaling pathwayMing Jing Shen, Yuhchyau Chen|Oncotarget|2017Cited by 73
A FASN-TGF-β1-FASN regulatory loop contributes to high EMT/metastatic potential of cisplatin-resistant non-small cell lung cancerYang Li, Yuhchyau Chen|Oncotarget|2016Cited by 62
Increased infiltration of macrophages to radioresistant lung cancer cells contributes to the development of the additional resistance of tumor cells to the cytotoxic effects of NK cellsMingjing Shen, Yuhchyau Chen|International Journal of Oncology|2018Cited by 5
Dosimetric changes achieved and changes in target and parotid volumes in patients undergoing adaptive planning during chemoradiation therapy with helical delivery of treatmentMichael Cummings, Deepinder Singh, Mary Z. Hare et al.|Journal of Radiotherapy in Practice|2019Cited by 1